Beyond metabolism, ERRα enhances tumor cell survival by upregulating anti-apoptotic and proliferative genes such as BCL2, Cyclin D1, and c-Myc, and by activating key oncogenic signaling pathways like PI3K/Akt/mTOR and MAPK/ERK. This evidence concerns the gene ESRRA and neoplasm.